• Mashup Score: 1
    Treatment of Locally Advanced/Metastatic Colorectal Cancer - 3 year(s) ago

    Few treatment advances have been observed in recent years for the treatment of advanced colorectal cancer (CRC). The goal remains to find approaches beyond FOLFOX and bevacizumab that will prolong remission. Immunotherapy for patients with microsatellite instability–high tumors represents progress, but this is a very small subset and approximately 30% of patients will…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Alan P. Venook, MD, of @UCSF @UCSFCancer and Christopher G. Willett, MD, of @DukeCancer @DukeHealth discuss current and emerging treatment options for locally advanced/metastatic #colorectalcancer at the #NCCN2021 Virtual Annual Conference: https://t.co/dYESLZZyTQ #CRCSM https://t.co/IvfqsYIb0d

  • Mashup Score: 1
    Supportive Care in Head and Neck Cancers: Multidisciplinary Management - 3 year(s) ago

    Patients with head and neck cancer experience a broad array of negative quality-of-life issues, but particularly common are dental complications following radiation therapy, and compromised nutrition with significant weight loss. At the NCCN 2021 Virtual Annual Conference, a panel of experts used a case-based approach to discuss some of these common adverse effects of…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      #SupportiveCare in #HeadandNeckCancers: Multidisciplinary Management discussed by @JJCaudell of @MoffittNews, David Pfister, MD of @sloan_kettering, & @RandalSWeberMD of @MDAndersonNews @bcmhouston at the #NCCN2021 Virtual Annual Conference https://t.co/YuUBhIVTPq #supponc #hncsm https://t.co/qKka8stY36

  • Mashup Score: 0
    Keynote Session: Strategies for Prevention and Control of HPV-Associated Cancers - 3 year(s) ago

    Infection with HPV is responsible for 5% of cancers, most of which are preventable with vaccination. Unfortunately, although vaccination rates are increasing in the United States, many adolescents remain unvaccinated due to a multifactorial set of barriers that are cultural, psychosocial, structural, and financial. At this Keynote session at the NCCN 2021 Virtual…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Publication Alert: Summary of Keynote Session at #NCCN2021 Virtual Annual Conference Discussing Strategies for Prevention and Control of #HPV-Associated #Cancers: https://t.co/0ERNimoLoW #HPVCancer #CancerPrevention https://t.co/k5J7mqXHcv

  • Mashup Score: 0
    Update on CAR T-Cell Therapies for Relapsed/Refractory B-Cell Lymphomas - 3 year(s) ago

    CAR T cells are genetically engineered to produce an artificial receptor on the T-cell surface for use in immunotherapy, which immediately engages its target, results in CAR T-cell proliferation, and effects target cell cytotoxicity. Prior to CAR T-cell therapy, approximately 30% of patients with diffuse large B-cell lymphoma (DLBCL) had an unmet need for a new…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      An Update on #CARTcell Therapies for Relapsed/Refractory B-Cell Lymphomas, presented by Stephen J. Schuster, MD, of @PennCancer, @PennMedicine at the #NCCN2021 Virtual Annual Conference: https://t.co/Y1XQG3YoW6 #lymsm #NonHodgkinLymphoma #BCellLymphoma https://t.co/ov1HyYoEjF

  • Mashup Score: 0
    Keynote Session: Reducing Racial Disparities in Oncology—Recommendations for Implementing Guideline-Adherent Cancer Care - 3 year(s) ago

    Research shows that racial disparities exist in the delivery of guideline-adherent cancer care, and that non-White patients are less likely to receive guideline-concordant care than White patients, leading to worse health outcomes. However, these disparities are not often addressed. The Elevating Cancer Equity initiative aims to address these disparities through…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Publication Alert: Summary of keynote session at #NCCN2021 Virtual Annual Conference discussing joint #ElevatingCancerEquity initiative to address #racialdisparities in #cancercaredelivery: https://t.co/0TzsFQxfKh #healthdisparities #healthequity #cancerdisparities https://t.co/VN71SaEODP

  • Mashup Score: 0
    Helping Cancer Survivors Return to Work - 3 year(s) ago

    Work limitations due to health problems can range from mild or transient limitations to persistent, long‐term dysfunction and can lead to employment instability, underemployment, and even loss of employment. In fact, compared with a healthy matched control population, cancer survivors are 1.37 times more likely to be unemployed. Because patients with metastatic…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Publication Alert: "Helping #CancerSurvivors Return to Work," presented by @AmyeTevaarwerk1 of @uwsmph @UWCarbone at the #NCCN2021 Virtual Annual Conference: https://t.co/C5wtJlIVQ7 #survonc #oncology https://t.co/ICvj7LhziO

  • Mashup Score: 0
    Annual Conference - 3 year(s) ago

    This activity is supported by educational grants from Abbott’s molecular business; Adaptive Biotechnologies; AstraZeneca; BeiGene, Ltd.; Blueprint Medicines; Daiichi Sankyo; Deciphera Pharmaceuticals; Eisai; Exact Sciences; Genentech, a member of the Roche Group; Gilead Sciences; GlaxoSmithKline; GRAIL, Inc.; Ipsen Biopharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Pharmacyclics LLC, an…

    Source: NCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NCCN
      NCCN

      Recorded presentations from the #NCCN2021 Virtual Annual Conference are now available! #CME https://t.co/ui5cRdRCCe https://t.co/FGmBWeTn2i

  • Mashup Score: 1
    Wolters Kluwer Health - 3 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Source: journals.lww.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncologyTimes
      OncologyTimes

      Non-Hispanic Black patients with #LungCancer, in particular, are less likely to receive #cancertreatment following @NCCN guidelines, the researchers found based on data from the @StateMaryland. Read more: https://t.co/vsNwpRhmrk #LCSM #medtwitter (3/3)

    • Profile photo of OncologyTimes
      OncologyTimes

      “Many patients with #lungcancer in the U.S. receive no treatment or less-intensive treatment than recommended,” said study author @EvaValilis of @HopkinsMedicine. https://t.co/vsNwpRhmrk #LCSM #healthdisparity (2/3)

    • Profile photo of OncologyTimes
      OncologyTimes

      A new study found that sociodemographic factors such as #race, #income, and #healthinsurance status impact the receipt of #LungCancer treatment https://t.co/vsNwpRhmrk #LCSM #NCCN2021 (1/3) https://t.co/h3IIqWJyj1

  • Mashup Score: 0
    Sandy Srinivas on Managing Metastatic Castration-Resistant Prostate Cancer - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference Sandy Srinivas, MD, of Stanford Cancer Institute, discusses the increasing number of ways to deliver life-prolonging therapy to patients with advanced prostate cancer, including more accurate imaging techniques; PET tracers to help better detect, diagnose, and treat disease; PARP inhibitors for BRCA and other…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Sandy Srinivas, MD, on Managing Metastatic Castration-Resistant Prostate Cancer https://t.co/ABbzoz7eTV #pcsm #oncology #cancer #NCCN2021 #NCCN21 @sandysrimd @StanfordHealth https://t.co/TYkWNrVZh2

Load More